Merge
Welcome to our blog where you can be informed about the latest health and technology insights.
Filters
Showing results for
The 8 user requirements Merge PACS delivers on for reliable imaging
The biggest ways Merge PACS is providing reliable imaging, less complexity, and...
The 8 user requirements Merge PACS delivers on for reliable imaging
The biggest ways Merge PACS is providing reliable imaging, less complexity, and...
Trends for 2026: Targeted AI, continuous trials, and navigating uncertainty
In 2026, clinical trial teams must be prepared to navigate market uncertainty and...
Merge Hemo wins Best in KLAS 2026 for cardiology hemodynamics solutions
The story at a glance Merge Hemo ranks 2026 Best in KLAS for cardiology...
Merge Hemo wins Best in KLAS 2026 for cardiology hemodynamics solutions
The story at a glance Merge Hemo ranks 2026 Best in KLAS for cardiology...
What’s new in Merge PACS 9.4 - and why upgrade?
Merge PACS 9.4 marks a step forward for radiology departments and healthcare...
What’s new in Merge PACS 9.4 - and why upgrade?
Merge PACS 9.4 marks a step forward for radiology departments and healthcare...
How Merge VNA futureproofed imaging for a world-renowned UK children’s hospital
With Merge VNA, this children’s hospital achieved a secure and seamless PACS...
How Merge VNA futureproofed imaging for a world-renowned UK children’s hospital
With Merge VNA, this children’s hospital achieved a secure and seamless PACS...
A deep dive into hemodynamic calculations with Merge Hemo
Discover how Merge Hemo streamlines hemodynamic calculations like cardiac output,...
A deep dive into hemodynamic calculations with Merge Hemo
Discover how Merge Hemo streamlines hemodynamic calculations like cardiac output,...
How CDMS support services can make or break complex study rescues
When evaluating a CDMS partner, support services aren’t a nice-to-have—they’re...
The 24-hour study build is the future of clinical data management
Manual processes hold back clinical trials. Discover Zelta's vision for using AI to...
How ICH E6 (R3) is changing clinical trials
Discover how Zelta EDC aligns with ICH E6 (R3)
FSO vs FSP: One CRO highlights key considerations for your decision
This piece originally appeared on Pharmaceutical Technology. As the complexities of...
Strategic cardiology themes highlighted at the 2025 Merge User Conference
The 2025 Merge User Conference, held June 22-25 in Nashville, TN, brought together...
Strategic cardiology themes highlighted at the 2025 Merge User Conference
The 2025 Merge User Conference, held June 22-25 in Nashville, TN, brought together...
Zelta success stories: Streamlining clinical data collection, adding ePRO to EDC, and multi-point clinical data management
Making clinical study review simple and intuitive; putting clinical data managers in...
Platform trials: How to maximize results with an EDC platform
Platform trials offer increased flexibility and reduced costs for sponsors and CROs....
Zelta user success stories: Less stress, lower database costs, and fast-tracked clinical trials
Read about how Zelta brings database builds in-house, fast tracks clinical trials...
How supervised machine learning optimizes AI use in clinical trials
LLMs are frequently hailed as revolutionary tools in clinical trials. Read how...
Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses
This article originally appeared on Pharmaceutical Technology.2025 is set to be...
A toothy approach to innovating randomization in clinical trials
In a recent webinar, Solventum revealed how the Zelta eClinical platform helped...
Merge takeaways from RSNA to guide your 2025
Enterprise imaging strategies, the clinician’s view on cybersecurity, and more...
Merge takeaways from RSNA to guide your 2025
Enterprise imaging strategies, the clinician’s view on cybersecurity, and more...
The people-first approach transforming eClinical processes for clinical trials
Adding a “human at the center” perspective can help optimize clinical data...
The benefits of using the same clinical trials platform across phases
Sponsors can achieve greater efficiencies with a nimble clinical trials platform,...
How SaaS platforms are breaking the mold for clinical trials
With the right platform, SaaS systems can improve data accuracy, optimize costs, and...
Zelta ranks as Major Contender in Everest Group’s 2024 Clinical Data and Analytics PEAK Matrix report
We’re excited to announce that Zelta has been positioned as a Major Contender in the...
Summit Radiology selects Merge imaging solutions
Summit Radiology, a teleradiology practice based in northeast Indiana serving more...
Summit Radiology selects Merge imaging solutions
Summit Radiology, a teleradiology practice based in northeast Indiana serving more...
Let the use case decide: The Zelta way on AI and supervised machine learning
For decades, when people thought of artificial intelligence (AI) what usually...
Zelta user success stories: Faster timelines, cleaner data, in-house flexibility
This month we’re profiling just a few of the CROs, sponsors, biotech, and pharma...
Merge September 2024 newsletter: Thank you for joining us in Hartland
Hi Merge customers, We loved having you all join us at our home in Hartland for...
Merge September 2024 newsletter: Thank you for joining us in Hartland
Hi Merge customers, We loved having you all join us at our home in Hartland for...
Zelta ranked as a Leader in Everest Group’s 2024 EDC Products PEAK® Matrix Assessment
We’re excited to announce that Zelta has been officially ranked as a Leader in the...
Merge August 2024 newsletter: Last call for the Merge User Meeting
Hi Merge customers, I am looking forward to seeing you soon at our 2024 Merge User...
Merge August 2024 newsletter: Last call for the Merge User Meeting
Hi Merge customers, I am looking forward to seeing you soon at our 2024 Merge User...
Gene therapy: How Veristat cut trial database costs by 30%
This piece originally appeared in Pharmaceutical Technology. The gene therapy...
Merge July 2024 newsletter: Capping off a year of momentum with a Merge homecoming
Hi Merge customers, We are just two months away from our 2024 User Meeting in...
Untapped opportunities: Fulfilling the promise of decentralized clinical trials
This piece originally appeared in Pharmaceutical Technology. The uptake of...
Momentum at Merge: Reflecting on 1 year of growth
It was just over one year ago that I joined Merge. As I pause and reflect on that...
Merge June 2024 newsletter: Introducing Merge Consulting Services
Hi Merge customers, We’ve heard from you loud and clear about the ongoing staffing...
4 ways the vaccine rush is defining infectious disease trends for CROs in 2024
This piece originally appeared on Pharmaceutical Technology. The global healthcare...
Merge May 2024 newsletter: Join our Innovation Partner Program
Hi Merge customers, Earlier this year, we reintroduced our Innovation Partner...
The future of Zelta on display at the 2024 User Conference
That’s a wrap on the 2nd annual Zelta User Conference! We had a wonderful,...
Oncology in 2024: The clinical trial trends reshaping the role of CROs
This piece originally appeared on Pharmaceutical Technology. Oncology is the most...
Merge April 2024 newsletter: Bringing Best in KLAS to ACC
One of our favorite spring events is just around the corner! The American College...
Merge March 2024 newsletter: Welcome back to Merge Community
Merge customers, I hope you all have had a productive start to your year. At Merge,...
Four ways a holistic ecosystem for clinical trials can help boost ROI
This piece originally appeared on Clinical Leader Clinical trials are complex and...
Zelta surpasses 4,000 clinical trial studies
February 2024 marked a major milestone for Zelta: the platform has now hosted over...
Merge February 2024 newsletter: Merge ranks Best in KLAS 2024
Hello, Merge customers! Allow me to introduce myself – I’m Dr. Raj Chopra, the new...
Merge Cardio and Merge Hemo rank Best in KLAS 2024 for cardiology and hemodynamics
The top ranked Merge solutions will be showcased at ACC.24 in April
Merge January 2024 newsletter: A year of innovation, adoption, and focus starts now
Happy New Year! We hope you all had a wonderful, relaxing holiday break and that...
New research reveals state of healthcare’s evolving, but sporadic, journey to the cloud
Exclusive survey from Merge finds that, while 77% of medical imaging enterprises...
Merge December 2023 newsletter: Breaking ground at RSNA
Merge at RSNA 2023: Bringing Microsoft Azure availability and expanded 3D printing to Merge Imaging Suite
Merge November 2023 newsletter: Live from RSNA
Can Your Clinical Trial Design Handle Mid-Study Changes?
As clinical research advances, the pharmaceutical and biotech industries...
Merge October 2023 newsletter: Keeping patients at the center
October is Breast Cancer Awareness Month, a topic that is important to me personally...
Merge September 2023 newsletter: Takeaways from the Merge User Conference
This year’s Merge User Conference in Austin was another resounding success, filled...
5 takeaways from the 2023 Merge User Conference
This year’s Merge User Conference in Austin was another resounding success, filled...
Zelta expands its clinical trial ecosystem with a new partnership
At Zelta, we understand that collaboration is the name of the game when it comes to...
Lifesaving oncology research deserves cutting-edge solutions
The race to develop novel, advanced therapeutics for cancer patients is fast and...
New report confirms Zelta by Merative is a Major Contender
Merative has been named a Major Contender in Everest Group’s Life Sciences Clinical...
Merge August 2023 newsletter: Join our client success events
Hello Merge Customers, I want to take a moment to express my sincere gratitude for...
Merge July 2023 newsletter: Celebrating one year as Merative
One year ago this month, Merge officially became part of the Merative family. As...
Merative’s first year: Focus and progress
Standing up Merative was a bold, complex move. To mark our first anniversary on 1...
Merge June 2023 newsletter: From training to enablement
What’s the difference between training and enablement? The simple answer is that...
Three years after COVID-19, the conversation around DCTs is shifting again
While interest in decentralized clinical trials (DCTs) has been heating up lately,...
The disconnect between clinical trial technology and legacy habits
In today’s age of cloud computing and data integration solutions, there are simple...
Merge May 2023 newsletter: Your challenges are our challenges
Merge Customers, In my first month as general manager of our Merge portfolio, I’ve...
Merative Clinical Development has a new name
General Manager Jennifer Duff describes what the new name means for Merative’s...
Merge solutions win Best in KLAS 2023 for cardiology and hemodynamics
Merge April 2023 newsletter: Winning together
Merative names Ashish Sant as General Manager for Merge
Effective today, 12 April 2023, Ashish Sant will lead Merge, Merative’s...
Merge monthly newsletter: March 2023
Springing forward together
Connecting with the clinical development community
The time it takes to design, launch and complete clinical trials is a problem many...
Will DCTs finally democratize clinical trials?
Zelta Product Leader Walker Bradham and Senior Product Manager Wes Fishburne...
COVID-19 pandemic and patient centricity in clinical trials
Jennifer’s career as a clinical data management and clinical development executive...
Decentralized clinical trials are closer than you think
Jennifer’s career as a clinical data management and clinical development executive...